Lanreotide acetate

Also known as: Lanreotide acetate, BIM-23014C, Somatuline, Angiopeptin acetate, Somatuline Autogel, Somatuline LA, Somatuline LP, DC-13-116, 3-(2-Naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-threoninamide cyclic (2→7)-disulfide acetate, (4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-N-[(1S,2R)-1-carbamoyl-2-hydroxypropyl]-16-(4-hydroxybenzyl)-13-(1H-indol-3-ylmethyl)-7-isopropyl-19-{[3-(2-naphthyl)-D-alanyl]amino}-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide acetate

Lanreotide acetate (CAS 127984-74-1) is a compound in the Pharma Intermediates category listed in the Jingsj chemical database. It has the molecular formula C56H73N11O12S2 and a molecular weight of 1156.375 g/mol. It is classified under GHS with signal word Warning and hazard statements H361 — Suspected of damaging fertility or the unborn child. No supplier offers are currently listed; request a quote. Record last updated Aug 21, 2026.

CAS No.

127984-74-1

Jingsj CID

J-1528232-3

Molecular Formula

C₅₆H₇₃N₁₁O₁₂S₂

Molecular Weight

1156.375 g/mol

Category

Pharma Intermediates

Last updated

8/21/2026